There have been 194 positive COVID-19 test results from the community, as of 8am on Friday, since the last report from Public Health the day before.
In addition, there are 12 COVID-19 patients hospitalised, all in stable condition, an update from Public Health said.
Chief Medical Officer Dr John Lee reported that there have been 1,583 PCR tests conducted in the prior 24 hours.
According to information from Public Health, these results bring the number of active cases of COVID-19 in the Cayman Islands to 1,600.
The total number of cases recorded since the start of the pandemic stands at 2,676.
In addition, as of 8am Friday, Faith Hospital on Cayman Brac confirmed that in the Sister Islands there were 86 active cases, with 10 identified in the previous 24 hours. All new cases were from the community.
There have also been 116,671 COVID-19 vaccinations given in total to date, in the jurisdiction.
Of these, 56,908 (80% of 71,106) have had at least one dose of a COVID-19 vaccine and 54,711 (77%) have completed the two-dose course.
Additionally, 5,052 people (representing 27% of those over the age of 50) have had a third, or booster, dose
Meanwhile, Lee confirmed that government is “committed to ensuring the availability of COVID-19 vaccinations for children between the ages of five and 12 years old”, according to a press release.
However, Cayman’s vaccination programme is overseen by the UK government, which means the “use of the Pfizer-BioNTech vaccines for this age group must first be approved by the Medicines Healthcare products and Regulatory Agency of the UK”.
Following this, the Foreign, Commonwealth and Development Office would then be required to send the paediatric formulations to Cayman for roll-out.
The Cayman Islands government, the release said, is working closely with the Governor’s Office towards this end.
The release also said that the Governor’s Office has welcomed the news of the approval of molnupiravir for COVID treatment in the UK.
Molnupiravir is an anti-viral tablet, stored at room temperature, that can be used to reduce serious illness in COVID-19 patients, if deployed early in the course of the infection.
“We are working with the Cayman Islands Ministry of Health, the UK Health Security Agency, FCDO and the UK’s Department for Health and Social Care to confirm when the medication might be made available to the Overseas Territories,” the release stated.
How do you feel after reading this?